WHO approves second mpox vaccine
The World Health Organization on Tuesday approved an mpox vaccine from Japanese pharma company KM Biologics for emergency use, the second one to get the agency's seal of approval.
Nov 20, 2024
0
23
The World Health Organization on Tuesday approved an mpox vaccine from Japanese pharma company KM Biologics for emergency use, the second one to get the agency's seal of approval.
Nov 20, 2024
0
23
A National Institutes of Health (NIH)-funded clinical trial of an mpox vaccine in adolescents found it was safe and generated an antibody response equivalent to that seen in adults, according to a planned interim analysis ...
Oct 16, 2024
0
14
A study led by researchers at Beth Israel Deaconess Medical Center (BIDMC) has demonstrated that mpox antibody levels declined rapidly and nearly returned to baseline six to 12 months after patients received the mpox vaccination. ...
Oct 3, 2024
0
34
The mpox vaccination campaign in Democratic Republic of Congo has been pushed back, health authorities told AFP on Tuesday, with the exact start date unclear.
Oct 2, 2024
0
43
Youngsters have been especially impacted by mpox outbreaks raging in Africa, with children under five accounting for nearly a third of the cases in Burundi, the UN children's agency said Friday.
Sep 20, 2024
0
22
Mpox vaccines have been administered in Africa for the first time, with several hundred high-risk individuals vaccinated in Rwanda, the African Union's disease control center said Thursday.
Sep 19, 2024
0
40
Lessons learned from the COVID pandemic have left the world in a much better position to tackle the current mpox epidemic raging in Africa, according to the Gavi vaccine alliance.
Sep 19, 2024
0
39
The Gavi vaccine alliance announced Wednesday a deal with Danish drugmaker Bavarian Nordic to secure 500,000 jabs against mpox for use in African countries facing an epidemic of the virus.
Sep 18, 2024
0
22
Limited capacity is keeping Mpox testing coverage low in the DR Congo—the epicenter of the international emergency—the World Health Organization said Saturday in its latest situation report.
Sep 15, 2024
0
48
One dose of modified vaccinia Ankara-Bavarian Nordic (MVA-BN) smallpox vaccine is moderately effective in preventing mpox infection and should be made available to communities at risk, finds a study published by The BMJ .
Sep 11, 2024
0
37